Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR

Atlal El-Assaad1,2, Zaher Dawy3, Athar Khalil4

  • 1Department of Electrical and Computer Engineering, American University of Beirut (AUB), Riad El Solh, Beirut, Lebanon. atlal.assaad@liu.edu.lb.

Scientific Reports
|November 24, 2021
PubMed

Insights

This study models transcription factor GATA3 bound to DNA, identifying key amino acids and DNA bases critical for binding. These findings aid in understanding mutations in genetic disorders and cancer, guiding drug design.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Structural Biology

Background:

  • Transcription factors (TFs) are crucial in biological processes, and mutations in TF genes are linked to human genetic disorders and cancer.
  • GATA3 is a TF implicated in various diseases, making its structure and mutation effects important research areas.

Purpose of the Study:

  • To investigate the structural and energetic effects of missense mutations in the GATA3 transcription factor and its DNA binding site.
  • To develop an in silico model for predicting the impact of mutations on TF:DNA complex stability.

Main Methods:

  • Generated all possible missense mutants for GATA3 protein and adjacent/opposite DNA bases in complex models.
  • Employed Poisson-Boltzmann electrostatic calculations and free energy calculations to assess binding changes.
  • Validated computational findings against existing experimental genetic data.

Main Results:

  • Identified specific amino acids and DNA bases that are key determinants of GATA3:DNA binding.
  • Demonstrated the utility of in silico modeling in predicting mutation effects on TF:DNA interactions.
  • Corroborated computational predictions with experimental genetic data.

Conclusions:

  • The developed in silico model provides a novel approach for scoring missense mutations in TF:DNA complexes.
  • This methodology can be applied to other transcription factors involved in genetic diseases and cancer, aiding therapeutic strategies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K